Alvotech Begins Trading on Nasdaq Stockholm, Expands Nordic Presence
Alvotech, the Icelandic biopharmaceutical company specialising in developing and manufacturing biosimilar medicines, began trading today on Nasdaq Sto...
Alvotech Poised for Rapid Growth Following Nasdaq Listing
Alvotech, the Icelandic biopharmaceutical company specialising in biosimilars, is anticipating significant growth following its recent listing on the ...
Alvotech and STADA Pave Way partner together
Alvotech, an Iceland-based global biopharmaceutical company, has announced that all intellectual property disputes with AbbVie related to its AVT02 bi...